HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Induction of apoptosis in human renal proximal tubular epithelial cells by Escherichia coli verocytotoxin 1 in vitro.

Abstract
Verocytotoxin 1 and 2 (VT1 and 2) produced by verocytotoxin-producing Escherichia coli have been considered to play an important role in the pathogenesis of glomerular and tubular damage in the epidemic form of hemolytic uremic syndrome (HUS). VTs are known to be cytotoxic to culture cells by inhibiting cellular protein synthesis. In this in vitro study, the mechanism(s) of tubular damage in HUS and the ability of VT1 to induce apoptosis in normal human renal proximal tubular epithelial cells (HRPTEC) were examined. VTI markedly reduced cell viability of HRPTEC and rapidly inhibited overall protein synthesis. VT1 directly induced apoptotic cell death in HRPTEC in a dose- and time-dependent fashion, and co-incubation with tumor necrosis factor-alpha enhanced the VT1-induced apoptosis. These results suggest that apoptosis induced by VT1, possibly in concert with host cytokines, in renal tubular cells may contribute to the tubular damage in HUS.
AuthorsT Kodama, K Nagayama, K Yamada, Y Ohba, Y Akeda, T Honda
JournalMedical microbiology and immunology (Med Microbiol Immunol) Vol. 188 Issue 2 Pg. 73-8 (Nov 1999) ISSN: 0300-8584 [Print] Germany
PMID10753058 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Bacterial Toxins
  • Shiga Toxin 1
Topics
  • Apoptosis (drug effects)
  • Bacterial Toxins (pharmacology)
  • Cells, Cultured (drug effects)
  • DNA Fragmentation
  • Epithelial Cells (drug effects, pathology)
  • Escherichia coli (chemistry)
  • Flow Cytometry
  • Hemolytic-Uremic Syndrome (pathology)
  • Humans
  • Kidney Tubules, Proximal (drug effects, pathology)
  • Shiga Toxin 1

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: